Kitsugi, K.; Kawata, K.; Murohisa, G.; Yoshizawa, Y.; Kimata, M.; Kobayashi, Y.; Unno, S.; Noritake, H.; Chida, T.; Hosoda, Y.
C-Reactive Protein Levels Predict Improvement in the Liver Functional Reserve by Long-Term Rifaximin Treatment. Diseases 2025, 13, 331.
https://doi.org/10.3390/diseases13100331
AMA Style
Kitsugi K, Kawata K, Murohisa G, Yoshizawa Y, Kimata M, Kobayashi Y, Unno S, Noritake H, Chida T, Hosoda Y.
C-Reactive Protein Levels Predict Improvement in the Liver Functional Reserve by Long-Term Rifaximin Treatment. Diseases. 2025; 13(10):331.
https://doi.org/10.3390/diseases13100331
Chicago/Turabian Style
Kitsugi, Kensuke, Kazuhito Kawata, Go Murohisa, Yashiro Yoshizawa, Masaharu Kimata, Yosuke Kobayashi, Shuhei Unno, Hidenao Noritake, Takeshi Chida, and Yoshisuke Hosoda.
2025. "C-Reactive Protein Levels Predict Improvement in the Liver Functional Reserve by Long-Term Rifaximin Treatment" Diseases 13, no. 10: 331.
https://doi.org/10.3390/diseases13100331
APA Style
Kitsugi, K., Kawata, K., Murohisa, G., Yoshizawa, Y., Kimata, M., Kobayashi, Y., Unno, S., Noritake, H., Chida, T., & Hosoda, Y.
(2025). C-Reactive Protein Levels Predict Improvement in the Liver Functional Reserve by Long-Term Rifaximin Treatment. Diseases, 13(10), 331.
https://doi.org/10.3390/diseases13100331
